securities class action

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

Beyond Meat faces securities class action over alleged asset impairment misstatements; lead plaintiff deadline is March 24, 2026.

Rosen Law Firm notifies Corcept investors about securities lawsuit alleging misrepresentation of relacorilant clinical data and concealment of FDA concerns during October 2024-December 2025.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

BlackRock TCP Capital faces securities lawsuit alleging NAV overstatement and misvaluation. Investors have until April 6, 2026, to join the class action.

Plug Power investors face April 3, 2026 deadline to join securities lawsuit alleging misleading DOE loan fund statements and hydrogen facility construction misrepresentations.

Rosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026.

Rosen Law Firm files securities class action against Paysafe Limited, alleging false statements about business operations and financial performance. Investors must act before lead plaintiff deadline.

Rosen Law Firm urges Kyndryl investors to retain counsel before April 13, 2026 deadline in securities class action over false financial disclosures.

Securities class action filed against $COTY for failing to disclose weakness in beauty and fragrance segments. Stock fell 22% following disappointing Q2 results and guidance withdrawal.

Rosen Law Firm sues Richtech Robotics for allegedly fabricating Microsoft partnership claims. Affected investors must secure counsel before April 3 lead plaintiff deadline.

Snowflake faces securities fraud suit after 18% stock drop on corrective disclosures regarding consumption patterns and $10B revenue target claims.

Law firm Levi & Korsinsky files class action against Inovio Pharmaceuticals for allegedly false statements regarding device manufacturing and FDA pathways from October 2023 to December 2025.

Nektar Therapeutics faces securities lawsuit over REZOLVE-AA trial enrollment irregularities. Eligible investors have until May 5, 2026 to pursue compensation.

Class action lawsuit filed against $LAKE alleging false statements about Pacific Helmets and Jolly acquisitions. Investors with claims must act before April 24, 2026 deadline.

Rosen Law Firm urges Navan (NAVN) IPO investors to join securities lawsuit by April 24, 2026, alleging misleading offering documents and undisclosed expense increases.

Securities class action filed against uniQure alleging FDA approval misrepresentations. April 13, 2026 deadline for lead plaintiff claims.

Securities class action filed against $PYPL for allegedly making false statements about 2027 financial targets and Branded Checkout growth. April 20, 2026 deadline for lead plaintiff claims.

$SLNO investors urged to join class action over undisclosed DCCR safety concerns; May 5, 2026 deadline.

Law firm investigates Zynex securities fraud claims; investors face April 2026 deadline for federal class action lawsuit over alleged revenue inflation and Tricare payment fraud.